Home Lundbeck

Lundbeck

In operation
Post-IPO Round
Pharmaceutical R&D Developer

Basic Information

Lundbeck is a global pharmaceutical company dedicated to improving the quality of life for patients with psychiatric and neurological disorders. To this end, Lundbeck engages in the research, development, production, marketing, and sales of pharmaceuticals worldwide. The company's products target disease areas such as depression, schizophrenia, Parkinson's disease, and Alzheimer's disease.
H. Lundbeck A/S
Denmark
more than 500 people
January 01, 2000
information@lundbeck.com